Douglas Flora: Second Annual Virtual Summit – The State of AI in Precision Oncology 2024
Douglas Flora shared on LinkedIn:
“Join us for the Second Annual Virtual Summit: The State of AI in Precision Oncology 2024
The future of cancer screening is here, and it’s powered by Artificial Intelligence!
We’re thrilled to invite you to an insightful summit on “The State of AI in Precision Oncology 2024”, led by founding Editor-in-Chief Dr. Douglas Flora and a distinguished group of pioneering physicians, oncologists, and AI experts. Together, they’ll explore the transformative role of AI in precision oncology through dynamic keynote presentations, thought-provoking panel discussions, and engaging fireside chats.
Don’t miss this unique opportunity to gain insights from leaders at the forefront of AI and oncology!
Date: Thursday, December 12, 2024
Time: 8:00 am PT | 11:00 am ET | 17:00 CET.”
Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023